Found 15 matching trials
ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) PHASE3 This is a Phase III, international, multicentre, randomised, double-blinded...
Show More Location
Grand Hopital de Charleroi - site Notre Dame
Learn More & Join Trial
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. PHASE2 The main objective of the trial is to assess impact of maintenance therapy ...
Show More Location
Institut Bergonié
Learn More & Join Trial
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases PHASE3 Prospective, multicenter, comparative, randomized placebo-controlled Phase ...
Show More Location
Pôle Santé Léonard de Vinci
Learn More & Join Trial
Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer PHASE3 The purpose of the study is to assess the efficacy and safety of BAY1841788...
Show More Location
Multiple Locations
Learn More & Join Trial
Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC PHASE3 The goal of this clinical trial is to compare the combination of Darolutami...
Show More Location
Multiple Locations
Learn More & Join Trial
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents PHASE3 The intention of the study is to demonstrate superiority of Saruparib (AZD5...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers PHASE2 This Investigator-initiated, Treatment of High-Risk Prostate Cancer Guided ...
Show More Location
ZAS Sint-Augustinus
Learn More & Join Trial
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate PHASE3 The purpose of this study is to determine the effectiveness of darolutamide...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies PHASE3 Researchers are looking for a better way to treat men at high-risk of bioch...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital - Phoenix - Cardiology
Learn More & Join Trial
Imaging Study to Compare Effects of Darolutamide and Enzalutamide With Respect to Placebo on the Blood Flow in the Brain in Healthy Male Volunteers. PHASE1 The current study would investigate the effects of a single dose of darolut...
Show More Location
Centre for Neuroimaging Sciences, King's College
Learn More & Join Trial